Sign in
4

Changes in Ownership

AMGEN INC Filed Acc 0001127602-22-024930

EVP, Research and Development gave up 2,440 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
REESE DAVID M EVP, Research and Development 2022-11-02 Shares withheld for taxes −2,440 $272.06 $663,826 48,136 D
Loading xslF345X03/form4.xml…